A 2.5 mg target dose is 2,500 mcg
Deficiency is also prevalent in seniors because the capacity to absorb vitamin B12 can diminish with age
At Perfect B in Doral, FL, our approach to tesamorelin is grounded in clinical honesty: the right peptide for the right patient, with realistic timelines and the monitoring to catch what a self-administered protocol cannot
From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
the dosing schedule differs